livehealth.store

Nilotinib recalls

Nilotinib products have been recalled 2 times, most recently on 11 Mar 2026. The recalling company is usually Cipla USA. The most common reason is potency & assay.

Total recalls2since 2026

Last 12 months2reported

Class I00% of total

Ongoing2latest 11 Mar 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 2 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 0 0%Class III 2 100%

Why nilotinib is recalled

Potency & Assay2100%

Companies

Cipla USA2100%

By year

20262100%

Ongoing nilotinib recalls

2 active

Reported	Class	Recall	Company	Reason	Where
11 Mar 2026Drug	CLASS III	Nilotinib Capsules recalled by Cipla USANilotinib	Cipla USA	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS III	Nilotinib Capsules recalled by Cipla USANilotinib	Cipla USA	Potency & Assay	Nationwide

All nilotinib recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
11 Mar 2026Drug	CLASS III	Nilotinib Capsules recalled by Cipla USANilotinib	Cipla USA	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS III	Nilotinib Capsules recalled by Cipla USANilotinib	Cipla USA	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.